Final height and insulin-like growth factor-1 in children with medulloblastoma treated with growth hormone

Child's Nervous System

Volumn 29, Issue 10, 2013, Pages 1859-1863

  Chae, Hyun Wook ^a   Park, Young Seok ^b   Kim, Dong Seok ^a   Kwon, Ah Reum ^a   Kim, Ho Seong ^a   Kim, Duk Hee ^a  

^a Yonsei University College of Medicine   (South Korea)

^b CHA University   (South Korea)

Author keywords

Final height; Growth hormone; Insulin like growth factor 1; Medulloblastoma

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ARTICLE; BODY HEIGHT; BRAIN SURGERY; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CHILD; CLINICAL ARTICLE; FEMALE; GROWTH HORMONE DEFICIENCY; HUMAN; MALE; MEDULLOBLASTOMA; MULTIMODALITY CANCER THERAPY; OUTCOMES RESEARCH; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; SCHOOL CHILD; TUMOR LOCALIZATION; TUMOR VOLUME;

BODY HEIGHT; CEREBELLAR NEOPLASMS; CHEMORADIOTHERAPY; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GROWTH DISORDERS; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MALE; MEDULLOBLASTOMA; NEUROSURGICAL PROCEDURES; RETROSPECTIVE STUDIES;

EID: 84884354996     PISSN: 02567040     EISSN: 14330350     Source Type: Journal    
DOI: 10.1007/s00381-013-2124-6     Document Type: Article

References (24)

1. Gilles FH, Sobel EL, Leviton A, Tavare CJ (1998) Clusters of histologic characteristics in children with infratentorial neuroglial tumors. The childhood brain tumor consortium. J Neurooncol 39:51-63
2. Packer RJ, Cogen P, Vezina G, Rorke LB (1999) Medulloblastoma: clinical and biologic aspects. Neuro Oncol 1:232-250
3. Muirhead SE, Hsu E, Grimard L, Keene D (2002) Endocrine complications of pediatric brain tumors: case series and literature review. Pediatr Neurol 27:165-170
4. Noorda EM, Somers R, van Leeuwen FE, Vulsma T, Behrendt H (2001) Adult height and age at menarche in childhood cancer survivors. Eur J Cancer 37:605-612
5. Helseth E, Due-Tonnessen B, Wesenberg F, Lote K, Lundar T (1999) Posterior fossa medulloblastoma in children and young adults (0-19 years): survival and performance. Childs Nerv Syst 15:451-455, discussion 456
6. Hyun SE, Lee BC, Suh BK, Chung SC, Ko CW, Kim HS, Lee KH, Yang SW, Shin CH, Hwang JS, Kim DH, Lim BK, Kim JD, Yoo HW, Kim HS, Chung WY, Park MJ, Woo YJ, Kim CJ, Lee DY, Kim EY, Choi JH, Han HS, Hwang IT, Kim HS (2012) Reference values for serum levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in Korean children and adolescents. Clin Biochem 45:16-21
7. Darzy KH, Shalet SM (2005) Hypopituitarism after cranial irradiation. J Endocrinol Investig 28:78-87
8. Brauner R, Czernichow P, Rappaport R, Lemerle J, Sarrazin D, Hirsch JF, Renier D, Zucker JM (1985) Statural growth following irradiation of the central nervous system for medulloblastoma of the posterior fossa. Retrospective analysis of 45 cases. Arch Fr Pediatr 42:219-223
9. Clayton P, Gleeson H, Monson J, Popovic V, Shalet SM, Christiansen JS (2007) Growth hormone replacement throughout life: insights into age-related responses to treatment. Growth Hormon IGF Res 17:369-382
10. Oberfield SE, Sklar CA (2002) Endocrine sequelae in survivors of childhood cancer. Adolesc Med 13:161-169, viii
11. Gleeson HK, Stoeter R, Ogilvy-Stuart AL, Gattamaneni HR, Brennan BM, Shalet SM (2003) Improvements in final height over 25 years in growth hormone (GH)-deficient childhood survivors of brain tumors receiving GH replacement. J Clin Endocrinol Metab 88:3682-3689
12. Lerner SE, Huang GJ, McMahon D, Sklar CA, Oberfield SE (2004) Growth hormone therapy in children after cranial/craniospinal radiation therapy: sexually dimorphic outcomes. J Clin Endocrinol Metab 89:6100-6104
13. Cohen P, Rogol AD, Howard CP, Bright GM, Kappelgaard AM, Rosenfeld RG (2007) Insulin growth factor-based dosing of growth hormone therapy in children: a randomized, controlled study. J Clin Endocrinol Metab 92:2480-2486
14. Juul A, Dalgaard P, Blum WF, Bang P, Hall K, Michaelsen KF, Muller J, Skakkebaek NE (1995) Serum levels of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in healthy infants, children, and adolescents: the relation to IGF-I, IGF-II, IGFBP-1, IGFBP-2, age, sex, body mass index, and pubertal maturation. J Clin Endocrinol Metab 80:2534-2542
15. Aguiar-Oliveira MH, Gill MS, de ABES, Alcantara MR, Miraki-Moud F, Menezes CA, Souza AH, Martinelli CE, Pereira FA, Salvatori R, Levine MA, Shalet SM, Camacho-Hubner C, Clayton PE (1999) Effect of severe growth hormone (GH) deficiency due to a mutation in the GH-releasing hormone receptor on insulin-like growth factors (IGFs), IGF-binding proteins, and ternary complex formation throughout life. J Clin Endocrinol Metab 84:4118-4126
16. Rosenfeld RG (1995) Broadening the growth hormone insensitivity syndrome. N Engl J Med 333:1145-1146
17. Rosenfeld RG, Buckway C, Selva K, Pratt KL, Guevara-Aguirre J (2004) Insulin-like growth factor (IGF) parameters and tools for efficacy: the IGF-I generation test in children. Horm Res 62(Suppl 1):37-43
18. Bouhours-Nouet N, Gatelais F, Boux de Casson F, Rouleau S, Coutant R (2007) The insulin-like growth factor-I response to growth hormone is increased in prepubertal children with obesity and tall stature. J Clin Endocrinol Metab 92:629-635
19. Ranke MB, Traunecker R, Martin DD, Schweizer R, Schwarze CP, Wollmann HA, Binder G (2005) IGF-I and IGF binding protein-3 levels during initial GH dosage step-up are indicators of GH sensitivity in GH-deficient children and short children born small for gestational age. Horm Res 64:68-76
20. Park P, Cohen P (2004) The role of insulin-like growth factor I monitoring in growth hormone-treated children. Horm Res 62(Suppl 1):59-65
21. Pawlikowska-Haddal A, Cohen P (2006) Advances in pediatric growth hormone therapy: IGF-I-based dosing. Indian Pediatr 43:577-581
22. Kim DHCH, Kwon MY, Kim HS (2007) Recurrence of brain tumors in patients treated with growth hormone. J Korean Soc Pediatr Endocrinol 12:99-103
23. Ogilvy-Stuart AL, Ryder WD, Gattamaneni HR, Clayton PE, Shalet SM (1992) Growth hormone and tumor recurrence. BMJ 304:1601-1605
24. Darendeliler F, Karagiannis G, Wilton P, Ranke MB, Albertsson-Wikland K, Anthony Price D, On Behalf Of The Kigs International B (2006) Recurrence of brain tumors in patients treated with growth hormone: analysis of KIGS (Pfizer International Growth Database). Acta Paediatr 95:1284-1290